Enhancing Decentralised Clinical Trials in Europe
5 Questions
3 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary aim of decentralised clinical trials (DCTs)?

  • To enhance the use of digital tools and telemedicine
  • To increase the number of clinical trial sites
  • To make clinical trials available to a wider demographic (correct)
  • To improve the robustness and reliability of data collected

    • Which entities have published recommendations to facilitate the conduct of DCTs?

  • EMA, ACT EU and HMA
  • EMA, HMA and EC (correct)
  • EC, HMA and ACT EU
  • ACT EU, EMA and EC

    • What is the ACT EU initiative?

  • A program to decentralise clinical trials
  • A program to speed up clinical trials in the European Union (correct)
  • A program to promote the use of digital tools and telemedicine
  • A program to ensure the well-being of participants

    • What enables the decentralisation of clinical trials?

    <p>The advancement of digital tools and telemedicine</p> Signup and view all the answers

    What is a potential benefit of DCTs?

    <p>Reduction in drop-out rates of clinical trials</p> Signup and view all the answers

    More Like This

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser